CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Ticker
- ACHV
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
- PRE 14A Proxy Proxy Statement (Preliminary)
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement · Agreement ended · New debt or obligation
- 4 Shares withheld for taxes President and CEO gave up 9,206 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, CMO gave up 4,376 shares (to pay taxes)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement · Regulation FD disclosure
- 8-K Event Other events
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes EVP, CMO gave up 1,310 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 3,401 shares (to pay taxes)
- 4 Open-market sale EVP, CMO sold 5,650 shares at $3.17 ($17,911)
Page 36 of 68 · 1,358 filings